This article demonstrates that the response to androgen deprivation therapy can be predicted by the presence of an alternative RNA form, or slice variant, of the androgen receptor in circulating tumor cells. The research therefore suggests that a simple blood test could predict the likelihood of a patient progressing to metastatic castration-resistant prostate cancer, which is associated with shorter overall survival. But importantly, not everything was bad news for patients with the androgen-receptor splice variant 7, as these patients were found to survive for longer periods when treated with taxane-based chemotherapy.No. 9 - "Studies That Led to FDA Approval of Axumin as Prostate Cancer Imaging Agent Presented at SNMMI 2016"
Understanding whether a prostate